Ambu A/S (OTCMKTS:AMBBY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $21.80 and last traded at $21.80, with a volume of 400 shares. The stock had previously closed at $20.05.
Ambu A/S Stock Performance
The firm’s fifty day moving average is $19.63 and its 200-day moving average is $17.86. The company has a current ratio of 2.53, a quick ratio of 1.49 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $5.12 billion and a PE ratio of 109.00.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last posted its earnings results on Tuesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $199.06 million during the quarter. Ambu A/S had a return on equity of 6.80% and a net margin of 7.23%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
- Five stocks we like better than Ambu A/S
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Stock Average Calculator
- MarketBeat Week in Review – 8/12 – 8/16
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
